GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Origin Therapeutics Holdings Inc (XCNQ:ORIG) » Definitions » Net Income Including Noncontrolling Interests

Origin Therapeutics Holdings (XCNQ:ORIG) Net Income Including Noncontrolling Interests : C$-2.90 Mil (TTM As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Origin Therapeutics Holdings's Net Income Including Noncontrolling Interests for the three months ended in Jun. 2023 was C$-0.06 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jun. 2023 was C$-2.90 Mil.


Origin Therapeutics Holdings Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Origin Therapeutics Holdings's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Net Income Including Noncontrolling Interests Chart

Origin Therapeutics Holdings Annual Data
Trend Sep21 Sep22
Net Income Including Noncontrolling Interests
- -1.45

Origin Therapeutics Holdings Quarterly Data
Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only -0.33 -0.55 -0.13 -2.15 -0.06

Origin Therapeutics Holdings Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Origin Therapeutics Holdings Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.


Origin Therapeutics Holdings (XCNQ:ORIG) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
505 Burrard Street, Suite 1570, Vancouver, BC, CAN, V7X 1M5
Origin Therapeutics Holdings Inc is an investment company focusing on investments in the psychedelic industry.

Origin Therapeutics Holdings (XCNQ:ORIG) Headlines

From GuruFocus

Paul Singer's 6 Largest New Holdings

By Sydnee Gatewood Sydnee Gatewood 11-28-2017

Ocean Rig: Growth And Dividends To Continue

By Faisal Humayun Faisal Humayun 05-11-2014

Third Avenue Management Comments on Ocean Rig UDW

By Holly LaFon Holly LaFon 11-01-2018

Ocean Rig: Expect Upside After Results And New Contract

By Faisal Humayun Faisal Humayun 05-19-2015

Ocean Rig: More Upside On Strong 2Q14 Results

By Faisal Humayun Faisal Humayun 08-18-2014

Strong Results Makes Ocean Rig Attractive

By Faisal Humayun Faisal Humayun 11-10-2014